Merck to Pay $950M to Settle Probe of Vioxx Marketing
Controversial painkiller was pulled from the market in 2004 due to heightened heart attack, stroke riskContinue Reading
Controversial painkiller was pulled from the market in 2004 due to heightened heart attack, stroke riskContinue Reading
Racial differences in survival were seen even among those with health insurance, study findsContinue Reading
Reports of influenza A were cut in half, researchers sayContinue Reading
Regular exams can prevent foot ulcers, nerve damage and amputations, podiatrists sayContinue Reading
Improper fit can result in serious injury, safety experts warnContinue Reading
Drug isn’t safe or effective for women with metastatic disease, agency saysContinue Reading
A rare form of blood cancerContinue Reading
Enhancing visual perceptions of words could help treat reading disorders, researchers sayContinue Reading
Agency says safety and effectiveness of the drug for this purpose hasn’t been provenContinue Reading
Treating chlamydia, gonorrhea and syphilis costs U.S. $17 billion a yearContinue Reading
Researchers say doctors may fear side-effects in the elderlyContinue Reading
Associated with emotional stress, clinical condition mimics a heart attackContinue Reading
First drug in U.S. sanctioned for myelofibrosisContinue Reading
It can lead to life-threatening infectionsContinue Reading
© 2021 TheHealthCast.com - All Rights Reserved.